190 related articles for article (PubMed ID: 29855072)
1. Case of psoriasiform and pustular eruptions in addition to alopecia as a paradoxical reaction induced by infliximab.
Shimokata M; Namiki T; Tokoro S; Ugajin T; Miura K; Yokozeki H
J Dermatol; 2018 Dec; 45(12):e331-e333. PubMed ID: 29855072
[No Abstract] [Full Text] [Related]
2. Psoriasiform and pustular eruption induced by infliximab.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
[TBL] [Abstract][Full Text] [Related]
3. Generalized Pustular Psoriasis Induced by Infliximab in a Patient With Inflammatory Bowel Disease.
Almutairi D; Sheasgreen C; Weizman A; Alavi A
J Cutan Med Surg; 2018; 22(5):507-510. PubMed ID: 29484893
[TBL] [Abstract][Full Text] [Related]
4. Persistent neutrophilic scarring alopecia triggered by anti-TNF blockade for Crohn's disease.
Amschler K; Mc Broekaert S; Mohr J; Schön MP; Mößner R
Eur J Dermatol; 2018 Jun; 28(3):403-405. PubMed ID: 29976546
[No Abstract] [Full Text] [Related]
5. Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab.
Medkour F; Babai S; Chanteloup E; Buffard V; Delchier JC; Le-Louet H
Gastroenterol Clin Biol; 2010 Feb; 34(2):140-1. PubMed ID: 20138448
[No Abstract] [Full Text] [Related]
6. Infliximab-induced acne and acute localized exanthematous pustulosis: Case report.
Senilă S; Seicean A; Fechete O; Grad A; Ungureanu L
Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28976720
[No Abstract] [Full Text] [Related]
7. Solitary facial cutaneous chronic inflammatory lesions induced by anti-tumour necrosis factor-α antagonist.
Haro-Gabaldón V; Ruiz Molina I; Haro-González-Vico V; Solís García E
Clin Exp Dermatol; 2019 Jan; 44(1):80-82. PubMed ID: 30255515
[No Abstract] [Full Text] [Related]
8. Induction of pustular lesions during infliximab therapy for Crohn's disease.
Pérez-Pérez L; Caeiro JL; Fabeiro JM; Allegue F; Zulaica A
Acta Derm Venereol; 2008; 88(3):292-3. PubMed ID: 18480940
[No Abstract] [Full Text] [Related]
9. Tumor Necrosis Factor Inhibitor-Induced Psoriasis in a Pediatric Crohn's Disease Patient Successfully Treated with Ustekinumab.
Bonomo L; de Moll EH; Li L; Geller L; Gordon MI; Dunkin D
J Drugs Dermatol; 2020 Mar; 19(3):328-331. PubMed ID: 32550694
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of pustular psoriasis after treatment of Crohn disease with infliximab.
Pourciau C; Shwayder T
Pediatr Dermatol; 2010; 27(5):539-40. PubMed ID: 20796241
[TBL] [Abstract][Full Text] [Related]
11. An Unusual Cause of Skin Rash in Crohn's Disease.
Chebli JMF; de Oliveira Moreira B; da Rocha Ribeiro TC
Gastroenterology; 2018 Sep; 155(3):618-620. PubMed ID: 29409941
[No Abstract] [Full Text] [Related]
12. Pustular psoriasis induced by terbinafine : differential diagnosis from acute generalized exanthematous pustulosis.
Tokuyama Y; Senoh A; Setsu N; Iwatsuki K
Eur J Dermatol; 2008; 18(6):725-6. PubMed ID: 19049946
[No Abstract] [Full Text] [Related]
13. Infliximab-induced follicular mucinosis of the face.
Williams RF; Hoang MP; Kroshinsky D; Smith GP
Int J Dermatol; 2017 Feb; 56(2):215-217. PubMed ID: 27336710
[No Abstract] [Full Text] [Related]
14. Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn's Disease.
Cankurtaran E; Ekiz F; Hamamci M; Akinci H; Coskun Y; Yuksel I
Dig Dis Sci; 2016 Apr; 61(4):1206-7. PubMed ID: 26894400
[No Abstract] [Full Text] [Related]
15. Palmoplantar pustulosis by adalimumab in a patient with Crohn disease.
Ortiz Salvador JM; Cubells Sánchez L; Subiabre Ferrer D
Med Clin (Barc); 2016 Dec; 147(12):565. PubMed ID: 27431884
[No Abstract] [Full Text] [Related]
16. Infliximab-induced skin manifestations in patients with inflammatory bowel disease.
Hellström AE; Färkkilä M; Kolho KL
Scand J Gastroenterol; 2016; 51(5):563-71. PubMed ID: 26728295
[TBL] [Abstract][Full Text] [Related]
17. Mycosis Fungoides-like Eruption and Infliximab.
Ganzetti G; Molinelli E; Campanati A; Brisigotti V; Goteri G; Consales V; Racchini S; Bendia E; di Sario A; Benedetti A; Offidani A
J Clin Gastroenterol; 2016 Aug; 50(7):610-1. PubMed ID: 26974764
[No Abstract] [Full Text] [Related]
18. Alopecia secondary to anti-tumor necrosis factor-alpha therapy.
Ribeiro LB; Rego JC; Estrada BD; Bastos PR; Piñeiro Maceira JM; Sodré CT
An Bras Dermatol; 2015; 90(2):232-5. PubMed ID: 25830994
[TBL] [Abstract][Full Text] [Related]
19. Psoriasiform Eruption Secondary to the Use of Adalimumab.
Esteves PM; Barbalho MG; Cortes JG; Cuzzi T; Sodre CT; Ramos-e-Silva M
J Drugs Dermatol; 2015 Oct; 14(10):1152-4. PubMed ID: 26461828
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
Faivre C; Villani AP; Aubin F; Lipsker D; Bottaro M; Cohen JD; Durupt F; Jeudy G; Sbidian E; Toussirot E; Badot V; Barbarot S; Debarbieux S; Delaporte E; Goegebeur G; Morel J; Nassif A; Duru G; Jullien D;
J Am Acad Dermatol; 2016 Jun; 74(6):1153-9. PubMed ID: 26965410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
